Welcome to the ePoster Viewing Panel of AICOG 2025

Introduction ? MRKH Syndrome is a congenital condition characterised by embryologic underdevelopment of the Mullerian duct ? incidence is 1 per 4,500?5,000 females ? 53% have congenital anomalies, involving urinary tract and skeleton Aims and objectives ? correct diagnosis of the underlying condition ? evaluation for associated congenital anomalies ? psychosocial counselling in addition to treatment or intervention to address the functional effects of genital anomalies should be attempted. Materials and method ? 16-year-old came with c/o primary amenorrhea associated with cyclical pain abdomen, every month for 3-4 days over 3 years. On examination- vitals were stable, secondary sexual characteristics were of tanner stage 4 with normal abdominal and external genital examination noted. ? USG findings confirmed with MRI -hypoplastic uterus with bicornuate configuration, right polycystic ovarian pattern, functional left ovarian cyst, caudate lobe hypertrophy of liver, ectopic Malrotated left kidney. ? Peripheral blood karyotyping- 46XX with normal hormonal levels Results ? Progesterone only pills were given for 6 months ? Psychological support given and encouraged to connect with peer support groups. ? Treatment options including vaginal elongation and the surgical creation of a neovagina before resumption of sexual activity explained ? Counselling regarding the future fertility options of adoption and gestational surrogacy given Conclusion ? There is a need for increased awareness and education about MRKH syndrome to identify more cases, promote understanding and reduce stigma ? To promote research in treatment options, potential future therapies and advancement in reproductive technologies that may benefit those with MRKH syndrome in future